annual D&A:
$1.06B-$94.00M(-8.15%)Summary
- As of today (May 29, 2025), TEVA annual depreciation & amortization is $1.06 billion, with the most recent change of -$94.00 million (-8.15%) on December 31, 2024.
- During the last 3 years, TEVA annual D&A has fallen by -$271.00 million (-20.38%).
- TEVA annual D&A is now -49.86% below its all-time high of $2.11 billion, reached on December 31, 2017.
Performance
TEVA Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$244.00M-$25.00M(-9.29%)Summary
- As of today (May 29, 2025), TEVA quarterly depreciation & amortization is $244.00 million, with the most recent change of -$25.00 million (-9.29%) on March 31, 2025.
- Over the past year, TEVA quarterly D&A has dropped by -$28.00 million (-10.29%).
- TEVA quarterly D&A is now -57.71% below its all-time high of $577.00 million, reached on September 30, 2016.
Performance
TEVA quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.03B-$28.00M(-2.64%)Summary
- As of today (May 29, 2025), TEVA TTM depreciation & amortization is $1.03 billion, with the most recent change of -$28.00 million (-2.64%) on March 31, 2025.
- Over the past year, TEVA TTM D&A has dropped by -$90.00 million (-8.03%).
- TEVA TTM D&A is now -51.80% below its all-time high of $2.14 billion, reached on March 31, 2018.
Performance
TEVA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TEVA Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.2% | -10.3% | -8.0% |
| 3 y3 years | -20.4% | -24.5% | -19.3% |
| 5 y5 years | -38.5% | -38.9% | -38.6% |
TEVA Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.4% | at low | -31.8% | at low | -22.5% | at low |
| 5 y | 5-year | -38.5% | at low | -38.9% | at low | -38.6% | at low |
| alltime | all time | -49.9% | +7573.9% | -57.7% | +539.6% | -51.8% | >+9999.0% |
TEVA Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $244.00M(-9.3%) | $1.03B(-2.6%) |
| Dec 2024 | $1.06B(-8.2%) | $269.00M(+3.9%) | $1.06B(+0.3%) |
| Sep 2024 | - | $259.00M(0.0%) | $1.06B(-2.2%) |
| Jun 2024 | - | $259.00M(-4.8%) | $1.08B(-3.7%) |
| Mar 2024 | - | $272.00M(+2.3%) | $1.12B(-2.8%) |
| Dec 2023 | $1.15B(-11.9%) | $266.00M(-6.0%) | $1.15B(-3.4%) |
| Sep 2023 | - | $283.00M(-5.7%) | $1.19B(-3.1%) |
| Jun 2023 | - | $300.00M(-1.3%) | $1.23B(-4.5%) |
| Mar 2023 | - | $304.00M(-0.7%) | $1.29B(-1.5%) |
| Dec 2022 | $1.31B(-1.7%) | $306.00M(-4.7%) | $1.31B(-1.1%) |
| Sep 2022 | - | $321.00M(-10.3%) | $1.32B(-0.6%) |
| Jun 2022 | - | $358.00M(+10.8%) | $1.33B(+4.2%) |
| Mar 2022 | - | $323.00M(+0.9%) | $1.28B(-4.0%) |
| Dec 2021 | $1.33B(-14.6%) | $320.00M(-2.7%) | $1.33B(-5.3%) |
| Sep 2021 | - | $329.00M(+7.9%) | $1.41B(-3.6%) |
| Jun 2021 | - | $305.00M(-18.9%) | $1.46B(-5.0%) |
| Mar 2021 | - | $376.00M(-4.8%) | $1.53B(-1.5%) |
| Dec 2020 | $1.56B(-9.6%) | $395.00M(+3.7%) | $1.56B(-1.3%) |
| Sep 2020 | - | $381.00M(-0.3%) | $1.58B(-2.0%) |
| Jun 2020 | - | $382.00M(-4.3%) | $1.61B(-4.1%) |
| Mar 2020 | - | $399.00M(-4.1%) | $1.68B(-2.6%) |
| Dec 2019 | $1.72B(-6.5%) | $416.00M(+0.7%) | $1.72B(+2.0%) |
| Sep 2019 | - | $413.00M(-8.2%) | $1.69B(-3.5%) |
| Jun 2019 | - | $450.00M(+1.6%) | $1.75B(-1.6%) |
| Mar 2019 | - | $443.00M(+16.0%) | $1.78B(-3.5%) |
| Dec 2018 | $1.84B(-12.8%) | $382.00M(-19.4%) | $1.84B(-7.3%) |
| Sep 2018 | - | $474.00M(-1.0%) | $1.99B(-2.6%) |
| Jun 2018 | - | $479.00M(-5.5%) | $2.04B(-4.6%) |
| Mar 2018 | - | $507.00M(-4.0%) | $2.14B(+1.3%) |
| Dec 2017 | $2.11B(+38.6%) | $528.00M(+0.2%) | $2.11B(+10.2%) |
| Sep 2017 | - | $527.00M(-8.7%) | $1.92B(-2.5%) |
| Jun 2017 | - | $577.00M(+20.2%) | $1.97B(+15.7%) |
| Mar 2017 | - | $480.00M(+44.6%) | $1.70B(+11.5%) |
| Dec 2016 | $1.52B(+16.5%) | $332.00M(-42.5%) | $1.52B(-0.2%) |
| Sep 2016 | - | $577.00M(+86.1%) | $1.53B(+20.7%) |
| Jun 2016 | - | $310.00M(+1.6%) | $1.26B(-1.0%) |
| Mar 2016 | - | $305.00M(-9.0%) | $1.28B(-2.3%) |
| Dec 2015 | $1.31B(-13.3%) | $335.00M(+6.3%) | $1.31B(-2.5%) |
| Sep 2015 | - | $315.00M(-2.5%) | $1.34B(-3.3%) |
| Jun 2015 | - | $323.00M(-3.6%) | $1.39B(-3.5%) |
| Mar 2015 | - | $335.00M(-9.2%) | $1.44B(-4.6%) |
| Dec 2014 | $1.51B(-8.2%) | $369.00M(+2.2%) | $1.51B(-4.3%) |
| Sep 2014 | - | $361.00M(-3.5%) | $1.57B(-3.6%) |
| Jun 2014 | - | $374.00M(-7.4%) | $1.63B(-1.6%) |
| Mar 2014 | - | $404.00M(-7.3%) | $1.66B(+1.0%) |
| Dec 2013 | $1.64B | $436.00M(+4.1%) | $1.64B(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | $419.00M(+4.8%) | $1.60B(+0.4%) |
| Jun 2013 | - | $400.00M(+3.4%) | $1.59B(+1.0%) |
| Mar 2013 | - | $387.00M(-1.5%) | $1.58B(-7.7%) |
| Dec 2012 | $1.71B(+59.8%) | $393.00M(-4.6%) | $1.71B(+3.7%) |
| Sep 2012 | - | $412.00M(+7.3%) | $1.65B(+11.1%) |
| Jun 2012 | - | $384.00M(-26.0%) | $1.48B(+12.1%) |
| Mar 2012 | - | $519.00M(+56.3%) | $1.32B(+23.7%) |
| Dec 2011 | $1.07B(+9.4%) | $332.00M(+34.4%) | $1.07B(+8.3%) |
| Sep 2011 | - | $247.00M(+10.3%) | $987.00M(-1.2%) |
| Jun 2011 | - | $224.00M(-15.8%) | $999.00M(-0.9%) |
| Mar 2011 | - | $266.00M(+6.4%) | $1.01B(+3.2%) |
| Dec 2010 | $977.00M(+7.6%) | $250.00M(-3.5%) | $977.00M(+1.0%) |
| Sep 2010 | - | $259.00M(+11.2%) | $967.00M(+0.5%) |
| Jun 2010 | - | $233.00M(-0.9%) | $962.00M(-15.8%) |
| Mar 2010 | - | $235.00M(-2.1%) | $1.14B(+25.9%) |
| Dec 2009 | $908.00M(+84.2%) | $240.00M(-5.5%) | $908.00M(+15.5%) |
| Sep 2009 | - | $254.00M(-38.6%) | $786.00M(+19.3%) |
| Jun 2009 | - | $414.00M(+250.8%) | $659.00M(+33.7%) |
| Dec 2008 | $493.00M(-5.4%) | $118.00M(-7.1%) | $493.00M(-4.3%) |
| Sep 2008 | - | $127.00M(+4.1%) | $515.00M(+2.6%) |
| Jun 2008 | - | $122.00M(-3.2%) | $502.00M(-1.6%) |
| Mar 2008 | - | $126.00M(-10.0%) | $510.00M(-2.1%) |
| Dec 2007 | $521.00M(+20.9%) | $140.00M(+22.8%) | $521.00M(+7.4%) |
| Sep 2007 | - | $114.00M(-12.3%) | $485.00M(+0.8%) |
| Jun 2007 | - | $130.00M(-5.1%) | $481.10M(+0.0%) |
| Mar 2007 | - | $137.00M(+31.7%) | $481.00M(+11.6%) |
| Dec 2006 | $431.00M(+77.4%) | $104.00M(-5.5%) | $431.00M(-24.4%) |
| Sep 2006 | - | $110.10M(-15.2%) | $570.00M(+23.9%) |
| Jun 2006 | - | $129.90M(+49.3%) | $459.90M(+67.5%) |
| Mar 2006 | - | $87.00M(-64.2%) | $274.50M(+13.0%) |
| Dec 2005 | $243.00M(+11.5%) | $243.00M(-537.8%) | $243.00M(>+9900.0%) |
| Jun 2005 | - | -$55.50M(-200.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $55.50M | $55.50M |
| Dec 2004 | $218.00M(+70.7%) | - | - |
| Dec 2003 | $127.70M(+31.8%) | - | - |
| Dec 2002 | $96.90M(-11.2%) | - | - |
| Dec 2001 | $109.13M(+14.9%) | - | - |
| Dec 2000 | $94.98M(+38.8%) | - | - |
| Dec 1999 | $68.42M(+16.5%) | - | - |
| Dec 1998 | $58.74M(+13.0%) | - | - |
| Dec 1997 | $52.00M(+19.0%) | - | - |
| Dec 1996 | $43.70M(+32.4%) | - | - |
| Dec 1995 | $33.00M(+7.1%) | - | - |
| Dec 1994 | $30.80M(+57.1%) | - | - |
| Dec 1993 | $19.60M(+8.3%) | - | - |
| Dec 1992 | $18.10M(+31.2%) | - | - |
| Dec 1991 | $13.80M | - | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual depreciation & amortization?
- What is the all time high annual D&A for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual D&A year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly D&A year-on-year change?
- What is Teva Pharmaceutical Industries Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited TTM D&A year-on-year change?
What is Teva Pharmaceutical Industries Limited annual depreciation & amortization?
The current annual D&A of TEVA is $1.06B
What is the all time high annual D&A for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual depreciation & amortization is $2.11B
What is Teva Pharmaceutical Industries Limited annual D&A year-on-year change?
Over the past year, TEVA annual depreciation & amortization has changed by -$94.00M (-8.15%)
What is Teva Pharmaceutical Industries Limited quarterly depreciation & amortization?
The current quarterly D&A of TEVA is $244.00M
What is the all time high quarterly D&A for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly depreciation & amortization is $577.00M
What is Teva Pharmaceutical Industries Limited quarterly D&A year-on-year change?
Over the past year, TEVA quarterly depreciation & amortization has changed by -$28.00M (-10.29%)
What is Teva Pharmaceutical Industries Limited TTM depreciation & amortization?
The current TTM D&A of TEVA is $1.03B
What is the all time high TTM D&A for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high TTM depreciation & amortization is $2.14B
What is Teva Pharmaceutical Industries Limited TTM D&A year-on-year change?
Over the past year, TEVA TTM depreciation & amortization has changed by -$90.00M (-8.03%)